SillaJen, Inc. (215600.KQ)

KRW 2565.0

(0.79%)

Operating Income Summary of SillaJen, Inc.

  • SillaJen, Inc.'s latest annual operating income in 2023 was -21.34 Billion KRW , up 12.17% from previous year.
  • SillaJen, Inc.'s latest quarterly operating income in 2024 Q2 was -6.63 Billion KRW , down -28.31% from previous quarter.
  • SillaJen, Inc. reported an annual operating income of -24.44 Billion KRW in 2022, down -19.96% from previous year.
  • SillaJen, Inc. reported an annual operating income of -20.37 Billion KRW in 2021, up 41.21% from previous year.
  • SillaJen, Inc. reported a quarterly operating income of -6.63 Billion KRW for 2024 Q2, down -28.31% from previous quarter.
  • SillaJen, Inc. reported a quarterly operating income of -5.64 Billion KRW for 2023 Q3, down -0.67% from previous quarter.

Annual Operating Income Chart of SillaJen, Inc. (2023 - 2014)

Historical Annual Operating Income of SillaJen, Inc. (2023 - 2014)

Year Operating Income Operating Income Growth
2023 -21.34 Billion KRW 12.17%
2022 -24.44 Billion KRW -19.96%
2021 -20.37 Billion KRW 41.21%
2020 -34.66 Billion KRW 40.74%
2019 -58.49 Billion KRW 1.33%
2018 -59.27 Billion KRW -17.11%
2017 -50.61 Billion KRW -8.1%
2016 -46.82 Billion KRW -96.95%
2015 -23.77 Billion KRW -56.62%
2014 -15.18 Billion KRW 0.0%

Peer Operating Income Comparison of SillaJen, Inc.

Name Operating Income Operating Income Difference
HLB Co., Ltd. -125.02 Billion KRW 82.927%
iNtRON Biotechnology, Inc. -3.28 Billion KRW -549.806%
BINEX Co., Ltd. 1.04 Billion KRW 2148.029%
Bioneer Corporation 791.75 Million KRW 2796.025%
Anterogen.Co.,Ltd. -5.07 Billion KRW -320.704%
MEDIPOST Co., Ltd. -25.13 Billion KRW 15.061%
CrystalGenomics, Inc. -30.91 Billion KRW 30.949%
Helixmith Co., Ltd -35.24 Billion KRW 39.437%
Chabiotech Co.,Ltd. -9.42 Billion KRW -126.477%
Medy-Tox Inc. 17.32 Billion KRW 223.227%
Peptron, Inc. -15.6 Billion KRW -36.807%
Amicogen, Inc. 2.05 Billion KRW 1138.151%
Genexine, Inc. -41.24 Billion KRW 48.241%
HLB Therapeutics Co.,Ltd. -8.7 Billion KRW -145.347%
LegoChem Biosciences, Inc. -80.82 Billion KRW 73.589%
ALTEOGEN Inc. -9.73 Billion KRW -119.228%
PharmaResearch Co., Ltd. 100.81 Billion KRW 121.173%
JETEMA, Co., Ltd. 2.63 Billion KRW 910.508%
OliX Pharmaceuticals,Inc -18.18 Billion KRW -17.379%
Genomictree Inc. -17.3 Billion KRW -23.362%
MedPacto, Inc. -28.75 Billion KRW 25.759%
D&D Pharmatech -13.48 Billion KRW -58.279%
EASY BIO,Inc. 20.63 Billion KRW 203.464%
GI Innovation, Inc. -55.6 Billion KRW 61.611%